Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Q32 Bio Stock Skyrocketed Today


Shares of Q32 Bio (NASDAQ: QTTB) soared on Monday after the biotechnology company announced promising clinical trial results for its experimental hair loss treatment.

Image source: Getty Images.

A Phase 2a clinical study of Q32 Bio's investigational antibody treatment, bempikibart, in patients with severe or very severe alopecia areata met its primary efficacy goal.

Continue reading


Source Fool.com

Like: 0
Share

Comments